Headquarters
806 DENISE CT, MILL VALLEY, CA 94941-3719, US
MILL VALLEY, CA, US
DIMERX
From the company
DIMERx, Inc. is a clinical-stage biopharmaceutical company developing first-in-class, covalently linked dimer-based therapeutics to address major public-health challenges in pain management and the opioid crisis. Its pipeline includes DMX-101 (buprenorphine dimer, Phase 2), DMX-201 (arginine-agmatine dimer, IND-enabling) and DMX-105 (acetaminophen dimer, IND-enabling). Development is supported by competitive NIH awards, including an $18M mandate.
Products & services offered
Capabilities 6
Classifications
- Ownership classifications (2)
- Minority Owned Business, Subcontinent Asian American Owned
Facilities
Send your requirements
Quantities, certifications, and timing.